Vedanta’s five companies unlocked approximately 20% value following a major corporate restructuring. While four newly demerged businesses experienced early gains that turned into losses on their stock exchange debut, their combined value, along with the residual entity, saw a significant increase. This demerger aimed to simplify the group’s structure and unlock value for each pure-play business.
Molbio Diagnostics shares rally 9% as Jefferies initiates ‘high conviction top pick’ call for recently listed stock. Why is it bullish?
Molbio Diagnostics shares jumped after Jefferies initiated coverage with a Buy rating and named it a high-conviction top pick. The brokerage set a Rs 1,600
September 30, 2026